Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Lundin Mining Second Quarter 2023 Results

TORONTO, August 2, 2023 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) today reported net earnings attributable to Lundin Mining shareholders of $59.1 million ($0.08 per share) and  $205.7 million ($0.27 per share) for the three and six months ended June 30, 2023, respectively. The Company also generated adjusted earnings1 of $16.0 million ($0.02 per share) and adjusted EBITDA1 of $162.2 million in the second quarter. Adjusted earnings were $141.7 million  ($0.18 per share) and adjusted EBITDA were $499.1 million for the six months

NOBLE CORPORATION PLC ANNOUNCES SECOND QUARTER 2023 RESULTS

· Amplifying capital returns to shareholders with $60 million of share repurchases in Q2 and quarterly cash dividend initiated at $0.30 per share. · Total backlog grows by 9% to $5.0 billion with new contracts totaling $0.8 billion secured over the past three months. · Q2 Net Income of $66 million, Diluted Earnings Per Share of $0.45, Adjusted EBITDA of $188 million, net cash provided by operating activities of $211 million, and Free Cash Flow of $104 million. SUGAR LAND, Texas, Aug. 2, 2023 /PRNewswire/ -- Noble Corporation plc (NYSE: NE, CSE: NOBLE, "Noble", or the "Company")

Nordea Bank Abp: Repurchase of own shares on 02.08.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares02.08.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 02.08.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+---------+-------------------+-------------------+| Trading |Number of| Weighted average |Total cost, EUR* **||venue (MIC| shares |price / share, EUR*| || Code) | | ** | |+----------+---------+-------------------+-------------------+|XHEL |272,996 |10.11

Reorganisation

Scout Gaming Group AB (”SGG”, ”the Group” or "the Company") announces the completion of its previously announced transformation programme. This includes a divestment of the group’s Norwegian subsidiary Scout Gaming AS to its management. Scout Gaming AS will to a limited level continue to be engaged as a subcontractor to the group going forward. The reason behind the reorganisation is for the Group is to become leaner and more efficient in the delivery of services to the group’s B2B partners. The business undertook a thorough review process to determine how to best drive efficiency in

Transaction in Own Shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 02 August 2023 REDDE NORTHGATE PLC (“Redde Northgate” or the “Group” or the “Company”)   Transaction in Own Shares   Redde Northgate plc (LSE:REDD) announces that on 02 August 2023 it purchased the following number of its own shares to be held in treasury:   Class of shares :  Ordinary shares of 50p (“shares”)Number

Bittium Corporation: SHARE REPURCHASE 2.8.2023

Bittium Corporation  ANNOUNCEMENT  2.8.2023 Bittium Corporation: SHARE REPURCHASE 2.8.2023 In the Helsinki Stock Exchange Trade date           2.8.2023Bourse trade         BuyShare                  BITTIAmount             1 900 SharesAverage price/ share    4,0298 EURTotal cost            7 656,62 EUR Bittium Corporation now holds a total of 117 972 sharesincluding the shares repurchased on 2.8.2023 On behalf of Bittium Corporation Nordea Bank Oyj

#23-250 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

New Study Reveals Negative Impact of Common Food Emulsifiers on Gut Health

Polysorbate 20 and Polysorbate 80 were shown to damage the gut barrier, leading to cell death and inflammation –– even at doses 10 to 20 times lower than those currently authorized for use The findings illustrate the urgent need to use fine-scale immunology to evaluate safety and establish a new standard for consumer productsDavos, 2 August 2023   New Study Reveals Negative Impact of Common Food Emulsifiers on Gut Health   Polysorbate 20 and Polysorbate 80 were shown to damage the gut barrier, leading to cell death and inflammation –– even at doses 10 to 20 times lower than

#23-249 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0003328555 Issuer Name Fidelity Japan Trust PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Allspring Global Investments Holdings. City of registered office (if applicable) Menomonee Falls Country of registered office (if applicable) United States 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to

Multiconsult ASA - Share buyback

Multiconsult ASA (OSE: MULTI) announced on 5 July 2023 a non-discretionary agreement with ABG Sundal Collier for the repurchase of up to 500 000 of its ordinary shares in the market with employee share saving programme and executive management bonus schemes, or as consideration in connection with acquisitions.From 25 July – 2 Aug 2023, Multiconsult ASA has purchased a total of 6 550 own shares at Oslo Børs at an average price of NOK 155.5044 per share.  Aggregated overview of transactions per day: Overview oftransactionsDate Aggregated daily Weighted average Total

Proposed Bond Waiver

2 August 2023   IOG plc Proposed Bond Waiver IOG plc ("IOG", or "the Company"), (AIM: IOG.L) confirms that a further waiver ("the Waiver Agreement") in respect of certain terms of its €100 million senior secured bond ("Bond Terms") is being proposed to bondholders, having been agreed in principle with key bondholders.  The Waiver Agreement is intended to provide a further period of stability for the Company to address balance sheet challenges, with certain items under the Bond Terms to be waived or deferred for the period to 29 September 2023, including inter alia: · the

Realheart Announces Last day of Trading With BTU and First day of Trading With Warrants of Series TO2

Press Release, August 2, 2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY,  WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE FURTHER REGISTRATION OR ANY OTHER MEASURES. Scandinavian Real Heart AB (publ)’s (“Realheart” or the “Company”) rights issue, in which the subscription period ended on July 7, 2023, has now been

BioGaia appoints Theresa Agnew as new CEO

Today BioGaia´s board of directors has appointed Theresa P. Agnew as the new chief executive officer.Theresa Agnew is a global business leader with consumer healthcare, OTC, and medical device experience from leading companies such as GlaxoSmithKline (GSK), Essilor and Johnson & Johnson. She has extensive experience after more than 20 years in leadership roles, managing teams of more than 500 employees. She brings solid international experience having lived and worked in Europe, the US and Australia and the Far East. She has a deep understanding of, and success, in the international

Neonode to Report Second Quarter 2023 Results on August 10, 2023

STOCKHOLM, SWEDEN, August 2, 2023 — Neonode Inc. (NASDAQ: NEON), announced today that it will release the financial results for the three and six months ended June 30, 2023, on Thursday August 10, 2023.The Company will host a conference call Thursday August 10, 2023, at 10AM Eastern Daylight Time (EDT)/4PM Central European Summer Time (CEST) featuring remarks by, and Q&A with, Urban Forssell, CEO, and Fredrik Nihlén, CFO.  To join the conference call, please use the following link: https://www.redeye.se/events/920647/live-qneonode. For interested individuals unable to join the live

Computing graduate joins global network

A Computer Science graduate who travelled the world during his studies has returned home to a top job.Originally from Sussex, Kyle Ashbee chose to study BSc (Hons) Computer Science (Network Computing)  at Staffordshire University because of the course’s reputation, facilities and industry links. The 24-year-old, who now lives in Shelton, explained: “Staffordshire University is one of the best for networks as a whole. We have Cisco modelling labs here and a lot of industry standard equipment. There's also industry qualifications funded

Invitation to CTEKs presentation of the interim report

On August 9 at 09:00 CEST, CTEK will hold an audiocast in English. CTEK is represented by acting CEO Ola Carlsson and CFO Thom Mathisen, who present the interim report and answer questions. If you wish to participate via webcast, please use the link below. Via the webcast you can ask written questions. https://ir.financialhearings.com/ctek-q2-2023   If you wish to participate via teleconference, please register on the link below. After registration you will be provided with a phone number and a conference ID to access the conference. You can ask questions verbally via the

Eevia Health Plc receives a 1 MSEK/94 KEUR sales order for a Bilberry extract product

Eevia Health Plc, (”Eevia” or ”The Company”), has received a 94 KEUR sales order from a European nutraceutical brand owner.The customer is a European brand owner headquartered in Sweden. The customer develops and markets effective herbal dietary supplements, as well as cosmetics in over 50.000 pharmacies, health food shops, and other retail outlets across 36 countries, including China and USA. The sales value to Eevia of this new order is c. 94 000 EUR. The product is a Bilberry extract standardized for anthocyanins and is a repeat order. This is one of the customers Eevia services

Eevia Health Plc receives a 141 KSEK / 12 KEUR sales order from Germany

Eevia Health ("Eevia" or "The Company") received sales order for multiple products from a customer in Germany of c. 12 KEUR.The German customer develops and markets vegan vitamins, superfoods, and sports nutrition under well-known brands. They use high quality raw materials in their own, innovative recipes.  The company stands for strict quality control and exclusively vegan products. The order contained multiple products from Eevia´s portfolio. One of the products is Eevia’s branded ingredient Feno-Myrtillus® 25 Organic, which is a highly concentrated and organically certified bilberry

Eevia Health Plc receives a 191 KSEK / 16 KEUR sales order for a Bilberry extract product

Eevia Health Plc’s (”Eevia” or ”The Company”) has received a 16 KEUR sales order from French distributor Natural Ingredients, for Feno-Myrtillus 36 organic, an organically certified bilberry extractNatural Ingredients is specialized into the distribution of natural and functional ingredients for the food supplement industry in France and in Europe. The sales value to Eevia of this new order is c. KEUR 16 EUR. The product is Eevia’s branded ingredient Feno-Myrtillus® 36 Organic, which is a highly concentrated and organically certified bilberry extract with 36% anthocyanins. Eevia keeps

Asetek Presents Second Quarter 2023 Results on Wednesday, 9 August

Asetek will release its financial results for the second quarter and first half of 2023 on Wednesday, 9 August at 11:00 CEST. CEO André Sloth Eriksen and CFO Peter Dam Madsen will present the Company's results at 14:00 CEST and invite investors, analysts and media to join the presentation. The presentation is expected to last up to one hour, including Q&A, and can be followed via live webcast or conference call. Webcast - audio and slide presentation: Please join the results webcast via the following link: https://events.q4inc.com/attendee/155806683 Conference call - audio only:

Cline Scientific AB (publ) announces outcome of the rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE ADDITIONAL REGISTRATION OR OTHER ACTION. Cline Scientific AB (publ) ("Cline" or the "Company") today, August 2, 2023, announces the outcome of the rights issue of shares which was announced by press release on June 12, 2023 (the "Rights Issue"). The Rights Issue

Update on Global Hemp Group

02 August 2023 Apollon Formularies Plc   Update on Global Hemp Group   Apollon Formularies plc (AQSE: APOL, "Apollon" or the "Company"), a UK based international pharmaceutical company trading on the AQSE Growth Market, that is licenced to research, develop, process, and sell medical cannabis therapeutic products that include legal medical cannabis to treat various illnesses under medical supervision, announces that the Company will not be proceeding with proposed deal with Global Hemp Group Inc. (“GHG”) under  the binding letter of intent (“LOI”) released on the 12th of

There are no items matching the current filter
There are no more items matching the current filter
Back to top